APO Research

APO RESEARCH · REPORT

AI Dermatology Imaging

Selected research

Market Outlook & Growth Opportunities

Global AI Dermatology Imaging Market Outlook and Growth Opportunities 2026

Market perspective

The global AI Dermatology Imaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Dermatology Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Dermatology Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Dermatology Imaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Dermatology Imaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Dermatology Imaging market include Canfield Scientific, FotoFinder Systems, DermEngine, SkinVision, MetaOptima, Deep Ensemble, Mindera Health, Heine Optotechnik and Veriskin, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Dermatology Imaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Dermatology Imaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Dermatology Imaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Dermatology Imaging market.

AI Dermatology Imaging Segment by Company

Canfield Scientific

FotoFinder Systems

DermEngine

SkinVision

MetaOptima

Deep Ensemble

Mindera Health

Heine Optotechnik

Veriskin

Apollo TeleHealth

AI Dermatology Imaging Segment by Type

Dermoscopy Imaging

Total Body Photography

Multispectral Imaging

AI Dermatology Imaging Segment by Application

Hospitals

Dermatology Clinics

Tele-dermatology Providers

AI Dermatology Imaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Dermatology Imaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Dermatology Imaging key companies, revenue, market share, and recent developments.

3. To split the AI Dermatology Imaging breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Dermatology Imaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Dermatology Imaging significant trends, drivers, influence factors in global and regions.

6. To analyze AI Dermatology Imaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Dermatology Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Dermatology Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Dermatology Imaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Dermatology Imaging industry.

Chapter 3: Detailed analysis of AI Dermatology Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Dermatology Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Dermatology Imaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Dermatology Imaging Industry Trends Table 2. AI Dermatology Imaging Industry Drivers Table 3. AI Dermatology Imaging Industry Opportunities and Challenges Table 4. AI Dermatology Imaging Industry Restraints Table 5. Global AI Dermatology Imaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Dermatology Imaging Revenue Share by Company (2021-2026) Table 7. Global AI Dermatology Imaging Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Dermatology Imaging Key Company Manufacturing Base & Headquarters Table 9. Global AI Dermatology Imaging Company, Product Type & Application Table 10. Global AI Dermatology Imaging Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Dermatology Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dermoscopy Imaging Table 15. Significant Companies of Total Body Photography Table 16. Significant Companies of Multispectral Imaging Table 17. Global AI Dermatology Imaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global AI Dermatology Imaging Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global AI Dermatology Imaging Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global AI Dermatology Imaging Sales Value Share by Type (2021-2026) Table 21. Global AI Dermatology Imaging Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Dermatology Clinics Table 24. Significant Companies of Tele-dermatology Providers Table 25. Global AI Dermatology Imaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Dermatology Imaging Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI Dermatology Imaging Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI Dermatology Imaging Sales Value Share by Application (2021-2026) Table 29. Global AI Dermatology Imaging Sales Value Share by Application (2027-2032) Table 30. Global AI Dermatology Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Dermatology Imaging Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI Dermatology Imaging Sales Value Share by Region (2021-2026) Table 33. Global AI Dermatology Imaging Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI Dermatology Imaging Sales Value Share by Region (2027-2032) Table 35. Global AI Dermatology Imaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Dermatology Imaging Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI Dermatology Imaging Sales Value Market Share by Country (2021-2026) Table 38. Global AI Dermatology Imaging Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI Dermatology Imaging Sales Value Market Share by Country (2027-2032) Table 40. Canfield Scientific Company Information Table 41. Canfield Scientific Business Overview Table 42. Canfield Scientific AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Canfield Scientific AI Dermatology Imaging Product Portfolio Table 44. Canfield Scientific Recent Development Table 45. FotoFinder Systems Company Information Table 46. FotoFinder Systems Business Overview Table 47. FotoFinder Systems AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. FotoFinder Systems AI Dermatology Imaging Product Portfolio Table 49. FotoFinder Systems Recent Development Table 50. DermEngine Company Information Table 51. DermEngine Business Overview Table 52. DermEngine AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. DermEngine AI Dermatology Imaging Product Portfolio Table 54. DermEngine Recent Development Table 55. SkinVision Company Information Table 56. SkinVision Business Overview Table 57. SkinVision AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. SkinVision AI Dermatology Imaging Product Portfolio Table 59. SkinVision Recent Development Table 60. MetaOptima Company Information Table 61. MetaOptima Business Overview Table 62. MetaOptima AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MetaOptima AI Dermatology Imaging Product Portfolio Table 64. MetaOptima Recent Development Table 65. Deep Ensemble Company Information Table 66. Deep Ensemble Business Overview Table 67. Deep Ensemble AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Deep Ensemble AI Dermatology Imaging Product Portfolio Table 69. Deep Ensemble Recent Development Table 70. Mindera Health Company Information Table 71. Mindera Health Business Overview Table 72. Mindera Health AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Mindera Health AI Dermatology Imaging Product Portfolio Table 74. Mindera Health Recent Development Table 75. Heine Optotechnik Company Information Table 76. Heine Optotechnik Business Overview Table 77. Heine Optotechnik AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Heine Optotechnik AI Dermatology Imaging Product Portfolio Table 79. Heine Optotechnik Recent Development Table 80. Veriskin Company Information Table 81. Veriskin Business Overview Table 82. Veriskin AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Veriskin AI Dermatology Imaging Product Portfolio Table 84. Veriskin Recent Development Table 85. Apollo TeleHealth Company Information Table 86. Apollo TeleHealth Business Overview Table 87. Apollo TeleHealth AI Dermatology Imaging Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Apollo TeleHealth AI Dermatology Imaging Product Portfolio Table 89. Apollo TeleHealth Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. AI Dermatology Imaging Product Image Figure 2. Global AI Dermatology Imaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Dermatology Imaging Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Dermatology Imaging Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dermoscopy Imaging Image Figure 8. Total Body Photography Image Figure 9. Multispectral Imaging Image Figure 10. Global AI Dermatology Imaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global AI Dermatology Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global AI Dermatology Imaging Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Dermatology Clinics Image Figure 15. Tele-dermatology Providers Image Figure 16. Global AI Dermatology Imaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Dermatology Imaging Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI Dermatology Imaging Sales Value Share by Application (2021-2032) Figure 19. Global AI Dermatology Imaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI Dermatology Imaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI Dermatology Imaging Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI Dermatology Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI Dermatology Imaging Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI Dermatology Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI Dermatology Imaging Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI Dermatology Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI Dermatology Imaging Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI Dermatology Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI Dermatology Imaging Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI Dermatology Imaging Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI Dermatology Imaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Dermoscopy Imaging
  • Total Body Photography
  • Multispectral Imaging
Applications
  • Hospitals
  • Dermatology Clinics
  • Tele-dermatology Providers
Companies covered
  • Canfield Scientific
  • FotoFinder Systems
  • DermEngine
  • SkinVision
  • MetaOptima
  • Deep Ensemble
  • Mindera Health
  • Heine Optotechnik
  • Veriskin
  • Apollo TeleHealth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Dermatology Imaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Dermatology Imaging Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Dermatology Imaging Market Dynamics
  1. 2.1 AI Dermatology Imaging Industry Trends
  2. 2.2 AI Dermatology Imaging Industry Drivers
  3. 2.3 AI Dermatology Imaging Industry Opportunities and Challenges
  4. 2.4 AI Dermatology Imaging Industry Restraints
3 AI Dermatology Imaging Market by Company
  1. 3.1 Global AI Dermatology Imaging Company Revenue Ranking in 2025
  2. 3.2 Global AI Dermatology Imaging Revenue by Company (2021-2026)
  3. 3.3 Global AI Dermatology Imaging Company Ranking (2024-2026)
  4. 3.4 Global AI Dermatology Imaging Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Dermatology Imaging Company Product Type and Application
  6. 3.6 Global AI Dermatology Imaging Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Dermatology Imaging Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Dermatology Imaging Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Dermatology Imaging Market by Type
  1. 4.1 AI Dermatology Imaging Type Introduction
  2. 4.1.1 Dermoscopy Imaging
  3. 4.1.2 Total Body Photography
  4. 4.1.3 Multispectral Imaging
  5. 4.2 Global AI Dermatology Imaging Sales Value by Type
  6. 4.2.1 Global AI Dermatology Imaging Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global AI Dermatology Imaging Sales Value by Type (2021-2032)
  8. 4.2.3 Global AI Dermatology Imaging Sales Value Share by Type (2021-2032)
5 AI Dermatology Imaging Market by Application
  1. 5.1 AI Dermatology Imaging Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Dermatology Clinics
  4. 5.1.3 Tele-dermatology Providers
  5. 5.2 Global AI Dermatology Imaging Sales Value by Application
  6. 5.2.1 Global AI Dermatology Imaging Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Dermatology Imaging Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Dermatology Imaging Sales Value Share by Application (2021-2032)
6 AI Dermatology Imaging Regional Value Analysis
  1. 6.1 Global AI Dermatology Imaging Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Dermatology Imaging Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Dermatology Imaging Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Dermatology Imaging Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Dermatology Imaging Sales Value (2021-2032)
  7. 6.3.2 North America AI Dermatology Imaging Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Dermatology Imaging Sales Value (2021-2032)
  10. 6.4.2 Europe AI Dermatology Imaging Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Dermatology Imaging Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Dermatology Imaging Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Dermatology Imaging Sales Value (2021-2032)
  16. 6.6.2 South America AI Dermatology Imaging Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Dermatology Imaging Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Dermatology Imaging Sales Value Share by Country, 2025 VS 2032
7 AI Dermatology Imaging Country-level Value Analysis
  1. 7.1 Global AI Dermatology Imaging Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Dermatology Imaging Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Dermatology Imaging Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Dermatology Imaging Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Dermatology Imaging Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Dermatology Imaging Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Dermatology Imaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Canfield Scientific
  2. 8.1.1 Canfield Scientific Company Information
  3. 8.1.2 Canfield Scientific Business Overview
  4. 8.1.3 Canfield Scientific AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Canfield Scientific AI Dermatology Imaging Product Portfolio
  6. 8.1.5 Canfield Scientific Recent Developments
  7. 8.2 FotoFinder Systems
  8. 8.2.1 FotoFinder Systems Company Information
  9. 8.2.2 FotoFinder Systems Business Overview
  10. 8.2.3 FotoFinder Systems AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  11. 8.2.4 FotoFinder Systems AI Dermatology Imaging Product Portfolio
  12. 8.2.5 FotoFinder Systems Recent Developments
  13. 8.3 DermEngine
  14. 8.3.1 DermEngine Company Information
  15. 8.3.2 DermEngine Business Overview
  16. 8.3.3 DermEngine AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DermEngine AI Dermatology Imaging Product Portfolio
  18. 8.3.5 DermEngine Recent Developments
  19. 8.4 SkinVision
  20. 8.4.1 SkinVision Company Information
  21. 8.4.2 SkinVision Business Overview
  22. 8.4.3 SkinVision AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SkinVision AI Dermatology Imaging Product Portfolio
  24. 8.4.5 SkinVision Recent Developments
  25. 8.5 MetaOptima
  26. 8.5.1 MetaOptima Company Information
  27. 8.5.2 MetaOptima Business Overview
  28. 8.5.3 MetaOptima AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MetaOptima AI Dermatology Imaging Product Portfolio
  30. 8.5.5 MetaOptima Recent Developments
  31. 8.6 Deep Ensemble
  32. 8.6.1 Deep Ensemble Company Information
  33. 8.6.2 Deep Ensemble Business Overview
  34. 8.6.3 Deep Ensemble AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Deep Ensemble AI Dermatology Imaging Product Portfolio
  36. 8.6.5 Deep Ensemble Recent Developments
  37. 8.7 Mindera Health
  38. 8.7.1 Mindera Health Company Information
  39. 8.7.2 Mindera Health Business Overview
  40. 8.7.3 Mindera Health AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mindera Health AI Dermatology Imaging Product Portfolio
  42. 8.7.5 Mindera Health Recent Developments
  43. 8.8 Heine Optotechnik
  44. 8.8.1 Heine Optotechnik Company Information
  45. 8.8.2 Heine Optotechnik Business Overview
  46. 8.8.3 Heine Optotechnik AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Heine Optotechnik AI Dermatology Imaging Product Portfolio
  48. 8.8.5 Heine Optotechnik Recent Developments
  49. 8.9 Veriskin
  50. 8.9.1 Veriskin Company Information
  51. 8.9.2 Veriskin Business Overview
  52. 8.9.3 Veriskin AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Veriskin AI Dermatology Imaging Product Portfolio
  54. 8.9.5 Veriskin Recent Developments
  55. 8.10 Apollo TeleHealth
  56. 8.10.1 Apollo TeleHealth Company Information
  57. 8.10.2 Apollo TeleHealth Business Overview
  58. 8.10.3 Apollo TeleHealth AI Dermatology Imaging Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Apollo TeleHealth AI Dermatology Imaging Product Portfolio
  60. 8.10.5 Apollo TeleHealth Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research